Angle PLC Announces Presentation of Data on Glioblastoma
Angle PLC Announces Board Changes
Angle PLC Announces Interim Results
Angle PLC Announces Change of Adviser
Angle PLC Announces Notice of Results
ANGLE Announces Collaboration with Myriad Genetics
Angle PLC announces novel findings using Parsortix (15.7000p, 0)
StreetAccount Summary - Trading higher/lower: EU mid-morning
ANGLE notes new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform (13.2500p, 0)
Angle PLC's Parsortix used in research paper from ETH Zurich (11.5000p, -0.5)
Powered by FactSet Research Systems Inc.